enVVeno Medical Corporation Common Stock
NVNO Real Time Price USDRecent trades of NVNO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NVNO's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
NVNO Revenue by Segment or Geography
New patents grants
-
Patent Title: Implantable vein frame Jan. 07, 2025
-
Patent Title: Implantable vein frame Jan. 16, 2024
-
Patent Title: Implantable vein frame Aug. 15, 2023
-
Patent Title: Biological valve for venous insufficiency Feb. 14, 2023
-
Patent Title: Biological valve for venous insufficiency Oct. 18, 2022
-
Patent Title: Biological valve for venous insufficiency May. 24, 2022
-
Patent Title: Biological valve for venous insufficiency Mar. 29, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to NVNO
Recent picks made for NVNO stock on CNBC
ETFs with the largest estimated holdings in NVNO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NVNO stock a Buy, Sell, or Hold?
- What is the price target for $NVNO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NVNO stock?
- Who owns the most shares of $NVNO stock?
- What funds own $NVNO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NVNO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.